Top Stories for the Week of Sept. 10th 2007

Friday, September 14, 2007 08:19 AM

Top News

 

Quintiles Launches Patient Website iGuard for Drug Safety Service

In an unusual move for a contract research organization (CRO), Research Triangle Park, N.C.,-based Quintiles has created a new service specifically for consumers of prescription drugs. The free service is called iGuard, a drug risk monitoring and personalized safety alert online site, and it’s a significant step toward patient-directed research.

ethica Creates Indian CRO Through Joint Venture

Montreal-based contract research organization (CRO) ethica Clinical Research has created a joint venture with Matrix Group, a healthcare company based in Hyderabad India. The new Indian CRO is called ethicamatrix. The model is similar to other recent partnerships, joint ventures and mergers between Western CROs and local entities in emerging markets such as India, China and countries in Eastern Europe. The strategy works because it leverages the existing local infrastructure with standardized, quality clinical trial management experience.

Other breaking news...      

Company Profile: An interview with Cristy Anderson, president, Clinical Research Advantage

To read the full articles for this issue or for more information on these and other breaking stories, pleaseclick herefor subscription information.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs